PTN 2 FOOTAGE
November 2004; 1 hour CME Credit
Two presentations:
- Jankovic on BoNT in CD
- Dolly on MOA of BoNT: Molecular Basis for the Therapeutic Effectiveness of BoNT
CD Contents:
- Epidemiology
- Diagnosis
- Clinical features
- Treatment
- Standards of clinical practice
- Evaluation of Patients with CD
- Strive to improve response
- Muscles to be treated
- Long-term efficacy of BoNT
- PatientTestimonial
©Neurotoxin Institute 2002-2007. Terms of Use
The NTI is supported by an unrestricted educational grant from Allergan Inc. The NTI is administered by 4D Communications. Powered by Asentia. |
|
